Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID‐19 AstraZeneca vaccination: A case report

Abstract

Abstract The patient was a 55‐year‐old female patient who presented with sudden onset of left hemiplegia, facial hemiparesis, and hypoesthesia. She has received her first dose of the AstraZeneca COVID‐19 vaccine. This case indicates that vaccination may raise the hypercoagulable state even in a condition of post‐ICH and anticoagulant prophylaxis.

Keywords

• cerebral venous sinus thrombosis
• ChAdOx1 nCoV‐19 vaccine
• intracerebral hemorrhage
• Oxford‐AstraZeneca COVID‐19 vaccine